Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Picard Medical, Inc. ( (PMI) ) is now available.
On December 4, 2025, Picard Medical, Inc. presented in vitro data on their Emperor Total Artificial Heart at the 31st Annual Meeting of the International Society for Mechanical Circulatory Support in Vienna. The Emperor TAH demonstrated comparable autoregulation and afterload independence to the pneumatic SynCardia Total Artificial Heart, showcasing its potential for stable hemodynamic performance and surgical feasibility in acute in vivo tests, which could pave the way for future clinical applications.
More about Picard Medical, Inc.
Picard Medical, Inc. operates in the medical device industry, focusing on developing advanced artificial heart technologies. Their primary product, the Emperor Total Artificial Heart, is a motor-driven evolution of the SynCardia Total Artificial Heart, designed to provide robust circulatory support for patients with end-stage biventricular heart failure.
Average Trading Volume: 2,044,057
See more data about PMI stock on TipRanks’ Stock Analysis page.